Finance

Lists
Why is ANVS down ၅.၃၉%?
Dive Deeper
ANVS:NYSE
Annovis Bio Inc
၀.၉၉ US$
-၅.၃၉%
(-၀.၀၅၇) 1D
၀.၉၉ US$
၀.၀၀% (၀.၀၀)
After hours
Closed: အောက် ၁၆, GMT-၄ ၁၆:၀၀:၀၆  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ANVS...
Open
၁.၀၆ US$
High
၁.၀၈ US$
Low
၀.၉၉ US$
Mkt. cap
၄.၂၄ ကုဋေ
Avg. vol.
၁.၂၁ သန်း
Volume
၆.၄၁ သိန်း
52-wk high
၅.၅၀ US$
52-wk low
၀.၉၉ US$
EPS
-၁.၇၈ US$
Beta
၁.၂၃
Shares outstanding
၄.၂၇ ကုဋေ
No. of employees
၈
Open
၁.၀၆ US$
High
၁.၀၈ US$
Low
၀.၉၉ US$
Mkt. cap
၄.၂၄ ကုဋေ
Avg. vol.
၁.၂၁ သန်း
Volume
၆.၄၁ သိန်း
52-wk high
၅.၅၀ US$
52-wk low
၀.၉၉ US$
EPS
-၁.၇၈ US$
Beta
၁.၂၃
Shares outstanding
၄.၂၇ ကုဋေ
No. of employees
၈
News stories
From web sources and news partners
Simply Wall Street
Simply Wall Street
·
ပြီးခဲ့သည့် ၁ နာရီ
What Kiniksa Holders Bought Into Before A 87% Run
ad-hoc-news.de
ad-hoc-news.de
·
ပြီးခဲ့သည့် ၁၈ မိနစ်
Eleven analysts target Ares Capital stock at USD 20.60
The Globe and Mail
The Globe and Mail
·
ပြီးခဲ့သည့် ၁ နာရီ
Ethereum Dramatically Outperformed the S&P 500 in Q3. Is It Finally Time to Load Up on Ethereum?
Yahoo Finance
Yahoo Finance
·
ပြီးခဲ့သည့် ၇ နာရီ
Wall Street’s record breakouts unravel as investors dump recent winners: Chart of the Day
About Annovis Bio Inc
CEOMaria-luisa Maccecchini
Employees၈
Founded၂၀၀၈
HeadquartersMalvern, ပင်ဆယ်ဗေးနီးယားပြည်နယ်, ယူနိုက်တက်စတိတ်
Sector-
Analyst ratings
Based on 3 analysts giving stock ratings to ANVS in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for ANVS in the last 3 months.
Highest
Current ၀.၉၉ US$
၁၇.၀၀ US$ (+၁,၆၁၁.၂၉%)
Average
၁၀.၆၇ US$ (+၉၇၄.၀၉%)
Lowest
၇.၀၀ US$ (+၆၀၄.၆၅%)
Analyst
Recommendation
Action
Price target
Projected
Date
Boobalan Pachaiyappan
Roth MKM
Buy
Maintained
၇.၀၀ US$
+၆၀၄.၇%
09/04/2026
Sumant Kulkarni
Canaccord Genuity
Buy
Reiterated
၁၇.၀၀ US$
+၁,၆၁၁.၃%
08/18/2026
Jason McCarthy
Maxim Group
Buy
Maintained
၈.၀၀ US$
+၇၀၅.၃%
08/17/2026
Unknown Analyst
Roth MKM
Buy
Initiated
၈.၀၀ US$
+၇၀၅.၃%
07/07/2026
Last report
၂၀၂၆ ဩ ၁၄
Fiscal period
Q2 2026
-၀.၄၀ US$ / -၀.၄၆ US$
+၁၃.၀၄%beat
Revenue / Est. (USD)
- / ၀.၀၀
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
၆.၂၉ သန်း
၈.၇၅ သန်း
၁.၆၇ ကုဋေ
၁.၂၀ ကုဋေ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၁.၁၄ သန်း
၉.၅၅ သိန်း
၁.၁၉ သန်း
၂.၃၇ သန်း
Operating expense
၇.၄၃ သန်း
၉.၇၁ သန်း
၁.၇၉ ကုဋေ
၁.၄၄ ကုဋေ
Total operating expenses
၇.၄၃ သန်း
၉.၇၁ သန်း
၁.၇၉ ကုဋေ
၁.၄၄ ကုဋေ
Operating income
-၇.၄၃ သန်း
-၉.၇၁ သန်း
-၁.၇၉ ကုဋေ
-၁.၄၄ ကုဋေ
Other non operating income
၂.၀၀ သောင်း
-၂.၉၆ သိန်း
၂.၆၈ သိန်း
-၆.၀၃ သိန်း
EBT including unusual items
-၇.၂၆ သန်း
-၉.၈၃ သန်း
-၁.၇၆ ကုဋေ
-၁.၄၈ ကုဋေ
EBT excluding unusual items
-၇.၂၆ သန်း
-၉.၈၃ သန်း
-၁.၇၅ ကုဋေ
-၁.၄၈ ကုဋေ
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-၇.၂၆ သန်း
-၉.၈၃ သန်း
-၁.၇၆ ကုဋေ
-၁.၄၈ ကုဋေ
Net profit margin
-
-
-
-
Earnings per share
-၀.၃၇
-၀.၃၉
-၀.၆၃
-၀.၄၀
Interest and investment income
၁.၅၂ သိန်း
၁.၆၈ သိန်း
၁.၃၈ သိန်း
၁.၆၀ သိန်း
Interest expense
-
-
-
-
Net interest expenses
၁.၅၂ သိန်း
၁.၆၈ သိန်း
၁.၃၈ သိန်း
၁.၆၀ သိန်း
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google အက်ပ်များ